Cyclopharm is an established Australian radiopharmaceutical company servicing the global medical community since 1986.

Cyclopharm is a company in the diagnostic imaging field specialising in lung health. We achieve this positioning through our proprietary medical device and pharmaceutical products under the name of TECHNEGASTM.

TECHNEGASTM has become the industry gold-standard in diagnostic functional lung imaging technology.

We distribute our products in 57 countries throughout the world with over 1500 nuclear medicine departments utilising TECHNEGASTM.

To date, over 4.2 million patient procedures are recorded.

Latest Media Releases

Cyclopharm Amended Constitution

04/05/2021 14:36:00

Please find attached CYC’s Amended Constitution adopted by special resolution at today’s Annual General Meeting.  For more information, download the attached PDF.

Cyclopharm - Results of Meeting

04/05/2021 14:18:00

In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act, we advise details of the resolutions and the proxies received in respect of each resolution in the attached voting r…

Latest News